share_log

Oppenheimer Upgrades Ventyx Biosciences to Outperform, Announces $12 Price Target

Oppenheimer Upgrades Ventyx Biosciences to Outperform, Announces $12 Price Target

奥本海默将Ventyx Biosciences上调至跑赢大盘,宣布目标股价为12美元
Benzinga ·  03/12 04:56

Oppenheimer analyst Jeff Jones upgrades Ventyx Biosciences (NASDAQ:VTYX) from Perform to Outperform and announces $12 price target.

奥本海默分析师杰夫·琼斯将Ventyx Biosciences(纳斯达克股票代码:VTYX)从表现上调至跑赢大盘,并宣布目标股价为12美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发